Legacy Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
Legacy Advisors's CL Position: Q1 2025 in Review
Legacy Advisors increased its Colgate-Palmolive (CL) stake by 24% in Q1 2025, buying an estimated $59K and bringing the position to 3,371 shares worth $316K. The position accounts for 0.03% of the portfolio, ranked #316.
Legacy Advisors first reported a position in CL in Q1 2018 and has held it in 18 quarters since. The position peaked at $367K in Q4 2022. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2025.
- Legacy Advisors held 3,371 shares of Colgate-Palmolive worth $316K as of Q1 2025.
- Legacy Advisors bought 659 Colgate-Palmolive shares in Q1 2025, an estimated $59K.
- Colgate-Palmolive made up 0.03% of Legacy Advisors's portfolio in Q1 2025, its #316 holding.
- Legacy Advisors first reported a position in Colgate-Palmolive in Q1 2018 and has held it in 18 quarters since.
- Legacy Advisors's Colgate-Palmolive position peaked at $367K in Q4 2022.
- 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.
Based on Legacy Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.